In recent years, albumin-to-fibrinogen ratio (AFR) was introduced as a novel combined biomarker which processed enhanced prognostic value in some malignancies, such as gastrointestinal cancer and breast cancer 13, 14. The gene discussed is ALB; the disease is breast cancer.